Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.
机构:[1]Oncology Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China[2]Integrative Medicine Department, First Clinical School, Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China
Primary clear cell carcinoma of the liver (PCCCL) is a rare and special type of primary hepatocellular carcinoma. However, treatment methods for multiple metastatic PCCCL are lacking. Here, we report the case of a 55-year-old male PCCCL patient with multiple metastatic lesions who was clinically cured by sunitinib-based systematic treatment. This patient was diagnosed with PCCCL in Liver Segment 7, Child-Pugh A liver function, Stage A in November 16, 2009, and received radical excision of the cancer immediately. His disease recurred with multiple metastatic lesions in the liver and other parts of the body, including the retroperitoneal lymph nodes, lung and bilateral adrenal nodules in June 29, 2012. The biopsy results showed that the lung mass was lung metastasis of PCCCL. With Child-Pugh A liver function, Stage C of PCCCL was diagnosed. Sunitinib (37.5 mg, oral, once a day [qd]) in combination with Chinese herbal medicine (CHM) was given. The tumor size steadily reduced, and the lesions were no longer obvious in May 21, 2014. The patient had multiple metastases and is in complete response (CR) state until now. He is considered as clinically cured. From the initial diagnosis of PCCCL, the survival period reached 8 years.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区医学
小类|3 区生物工程与应用微生物4 区肿瘤学
最新[2025]版:
大类|4 区医学
小类|4 区生物工程与应用微生物4 区肿瘤学
第一作者:
第一作者机构:[1]Oncology Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China[2]Integrative Medicine Department, First Clinical School, Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China
通讯作者:
通讯机构:[1]Oncology Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China[2]Integrative Medicine Department, First Clinical School, Guangzhou University of Chinese Medicine, Guangdong, People’s Republic of China[*1]Oncology Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No 16, Airport Road, Guangdong, Guangzhou 510405, People’s Republic of China
推荐引用方式(GB/T 7714):
Sun Lingling,Chen Hanrui,Xiao Zhiwei,et al.Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.[J].OncoTargets and therapy.2019,12:2823-2828.doi:10.2147/OTT.S197923.
APA:
Sun Lingling,Chen Hanrui,Xiao Zhiwei,Guo Wei&Lin Lizhu.(2019).Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report..OncoTargets and therapy,12,
MLA:
Sun Lingling,et al."Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.".OncoTargets and therapy 12.(2019):2823-2828